NCT02235415View on ClinicalTrials.gov

Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension

CompletedOBSERVATIONAL
Enrollment

24,526

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

September 30, 1999

Conditions
Hypertension
Interventions
DRUG

Motens® (lacidipine)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY